Title:
THE COMPOSITION COMPRISING RALOXIFENE WITH AT LEAST ONE ANTIPSYCHOTIC AGENT
Document Type and Number:
WIPO Patent Application WO/2019/203748
Kind Code:
A3
Abstract:
The present invention relates to a composition which comprises raloxifene or a pharmaceutically acceptable salt thereof and at least one antipsychotic agent or the pharmaceutically acceptable salt thereof and optionally at least one pharmaceutically acceptable excipient for simultaneous, separate or sequential use.
Inventors:
TÜRKYILMAZ ALI (TR)
PEHLIVAN AKALIN NUR (TR)
ERGUN DONMEZ MERVE (TR)
PEHLIVAN AKALIN NUR (TR)
ERGUN DONMEZ MERVE (TR)
Application Number:
PCT/TR2018/050780
Publication Date:
January 09, 2020
Filing Date:
December 07, 2018
Export Citation:
Assignee:
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI (TR)
International Classes:
A61K31/4535; A61K31/00; A61K45/06; A61P25/18
Other References:
KULKARNI, J. ET AL.: "Effect of adjunctive raloxifene therapy on severity of refractory schizophrenia in women: a randomized clinical trial", JAMA PSYCHIATRY, vol. 73, no. 9, 1 September 2016 (2016-09-01), pages 947 - 954, XP055670982, ISSN: 2168-622X, DOI: 10.1001/jamapsychiatry.2016.1383
KHODAIE-ARDAKANI, M. R. ET AL.: "A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia", ACTA MEDICA IRANICA, vol. 53, no. 6, 1 June 2015 (2015-06-01), pages 337 - 345, XP055670996
KHODAIE-ARDAKANI, M. R. ET AL.: "A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia", ACTA MEDICA IRANICA, vol. 53, no. 6, 1 June 2015 (2015-06-01), pages 337 - 345, XP055670996
Attorney, Agent or Firm:
SEVINC, Erkan (TR)
Download PDF: